Find, compare & contact
Promegestone
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Promegestone API 34184-77-5?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Promegestone. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Promegestone
- Synonyms:
- promegestona , Promegestone
- Cas Number:
- 34184-77-5
- DrugBank number:
- DB13602
- Unique Ingredient Identifier:
- 9XE0V2SQYX
General Description:
Promegestone is a chemical compound identified by the CAS number 34184-77-5. It is known for its distinct pharmacological properties and applications.
Classification:
Promegestone belongs to the class of organic compounds known as 20-oxosteroids. These are steroid derivatives carrying a C=O group at the 20-position of the steroid skeleton, classified under the direct parent group 20-oxosteroids. This compound is a part of the Organic compounds, falling under the Lipids and lipid-like molecules superclass, and categorized within the Steroids and steroid derivatives class, specifically within the Oxosteroids subclass.
Categories:
Promegestone is categorized under the following therapeutic classes: Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Norpregnadienes, Norpregnanes, Norsteroids, Pregnadien Derivatives, Progestins, Sex Hormones and Modulators of the Genital System, Steroids. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Promegestone is a type of Genitourinary Agents
Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.
These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.
Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.
These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.
In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.
